Nar Cancer
Overview
Nar Cancer is a scientific journal, published by Oxford University Press since 2019 in English. The journal's country of origin is United Kingdom and its primary focus area is oncology.
Details
Details
Abbr.
NAR Cancer
Publisher
Oxford University Press
Start
2019
End
Continuing
Frequency
Quarterly
e-ISSN
2632-8674
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 12997
17
SJR / Ranks: 1082
2127
CiteScore / Ranks: 4502
5.40
Recent Articles
1.
Espin R, Medina-Jover F, Siguenza-Andrade J, Farran-Matas S, Mateo F, Figueras A, et al.
NAR Cancer
. 2025 Mar;
7(1):zcaf007.
PMID: 40061566
Alternative end-joining (alt-EJ) is an error-prone DNA repair pathway that cancer cells deficient in homologous recombination rely on, making them vulnerable to synthetic lethality via inhibition of poly(ADP-ribose) polymerase (PARP)....
2.
Margalit S, Tulpova Z, Michaeli Y, Zur T, Deek J, Louzoun-Zada S, et al.
NAR Cancer
. 2025 Mar;
7(1):zcaf008.
PMID: 40061565
Cancer cells display complex genomic aberrations that include large-scale genetic rearrangements and epigenetic modulation that are not easily captured by short-read sequencing. This study presents a novel approach for simultaneous...
3.
Schott A, Simon T, Muller S, Rausch A, Busch B, Glass M, et al.
NAR Cancer
. 2025 Feb;
7(1):zcaf006.
PMID: 40008228
The Hippo/YAP1 signaling pathway regulates normal development by controlling contact inhibition of growth. In cancer, YAP1 activation is often dysregulated, leading to excessive tumor growth and metastasis. SRC kinase can...
4.
Doherty C, Wilbanks B, Jain S, S Pearson K, Bakken K, Burgenske D, et al.
NAR Cancer
. 2025 Feb;
7(1):zcaf005.
PMID: 39968526
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor of adults. Current therapeutic options yield dismal prognoses that have remained essentially unchanged over nearly two decades. Diffuse...
5.
Goncharov N, Baklanov I, Gulaia V, Shuliak A, Lanskikh D, Zhmenia V, et al.
NAR Cancer
. 2025 Feb;
7(1):zcaf003.
PMID: 39949830
Recently revised brain tumor classification suggested a glioma treatment strategy that takes into consideration molecular variants in and marker genes. While pathogenic variants of IDH1 and TP53 can be accompanied...
6.
Germoglio M, DAria F, Cortone G, Prodomo A, Mahtab M, Morigi R, et al.
NAR Cancer
. 2025 Feb;
7(1):zcaf004.
PMID: 39927196
G-quadruplex (G4) DNAs are alternative nucleic acid structures, proposed to play important roles in regulating DNA replication, gene transcription, and translation. Several specialized DNA helicases are involved in cellular G4...
7.
Sad K, Fawwal D, Jones C, Hill E, Skinner K, Adams M, et al.
NAR Cancer
. 2025 Feb;
7(1):zcaf002.
PMID: 39901931
Sequencing of human patient tumors has identified recurrent missense mutations in genes encoding core histones. We report that mutations that convert histone H3 amino acid 50 from a glutamate to...
8.
Morin C, Paraqindes H, Nguyen Van Long F, Isaac C, Thomas E, Pedri D, et al.
NAR Cancer
. 2025 Jan;
7(1):zcaf001.
PMID: 39877292
The epithelial-mesenchymal transition (EMT) is a dynamic transdifferentiation of epithelial cells into mesenchymal cells. EMT programs exhibit great diversity, based primarily on the distinct impact of molecular activities of the...
9.
Ahn B, Chou C, Chou C, Chen J, Zug A, Baykara Y, et al.
NAR Cancer
. 2025 Jan;
7(1):zcae047.
PMID: 39822275
Cancer is a complex disease with heterogeneous mutational and gene expression patterns. Subgroups of patients who share a phenotype might share a specific genetic architecture including protein-protein interactions (PPIs). We...
10.
Jimenez-Santos M, Garcia-Martin S, Rubio-Fernandez M, Gomez-Lopez G, Al-Shahrour F
NAR Cancer
. 2024 Dec;
6(4):zcae046.
PMID: 39703753
Breast cancer patients are categorized into three subtypes with distinct treatment approaches. Precision oncology has increased patient outcomes by targeting the specific molecular alterations of tumours, yet challenges remain. Treatment...